Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

302
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
302
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.4K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.4K
Design Consideration01:22

Design Consideration

582
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
582
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

702
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
702
Tensile Strength Considerations of Concrete01:16

Tensile Strength Considerations of Concrete

558
Considering the tensile strength of concrete involves recognizing that the theoretical strength of cement paste can be up to a thousand times higher than what is observed in practical applications. This significant discrepancy is largely attributed to the presence of microscopic cracks within the concrete. These cracks tend to amplify stress at their tips when a load is applied, a phenomenon explained by Griffith's theory of brittle fracture.
The dimensions and shape of a concrete specimen...
558
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

226
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
226

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations for Assessing Methodological Quality in Systematic Reviews of Population Pharmacokinetic Models: A Systematic Review.

Therapeutic drug monitoring·2026
Same author

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

The Journal of antimicrobial chemotherapy·2026
Same author

Adverse events in bedaquiline- and pretomanid-based regimens for drug-resistant tuberculosis from trial, implementation and pharmacovigilance studies.

British journal of clinical pharmacology·2026
Same author

Does one dose fit all in tuberculosis meningitis treatment?

The Journal of infectious diseases·2026
Same author

Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva.

Clinical pharmacokinetics·2026
Same author

Do we need to revise the dose of isoniazid for the treatment of tuberculosis in children?

The European respiratory journal·2026

Related Experiment Video

Updated: Feb 7, 2026

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

1.5K

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy.

B G J Dekkers1, A Veringa1, D J E Marriott2

  • 1Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands.

Drugs & Aging
|July 27, 2018
PubMed
Summary

Candida infections pose a growing threat to the elderly, leading to higher mortality rates. Optimal antifungal drug use in older adults faces challenges due to physiological changes and complex health conditions.

More Related Videos

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae
10:45

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae

Published on: July 30, 2012

15.2K
Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection
06:28

Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection

Published on: November 27, 2014

10.6K

Related Experiment Videos

Last Updated: Feb 7, 2026

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

1.5K
Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae
10:45

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae

Published on: July 30, 2012

15.2K
Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection
06:28

Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection

Published on: November 27, 2014

10.6K

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Candida infections present a significant and increasing clinical challenge in the elderly population.
  • Mortality rates for Candida infections are notably higher in older adults compared to younger individuals.
  • Factors contributing to this include increased immunocompromised individuals and emerging antifungal resistance.

Purpose of the Study:

  • To review current treatment options for Candida infections in the elderly.
  • To provide insights into the complexities of optimal antifungal drug administration in this demographic.
  • To address the unique challenges associated with treating fungal infections in older patients.

Main Methods:

  • Literature review of available treatment strategies for Candida infections.
  • Analysis of factors influencing antifungal drug efficacy and safety in the elderly.
  • Examination of pharmacokinetic and pharmacodynamic alterations in older individuals.

Main Results:

  • Elderly patients face heightened risks of adverse drug events due to physiological changes.
  • Organ dysfunction, comorbidities, and polypharmacy further complicate treatment decisions.
  • Optimal use of antifungals requires careful consideration of individual patient factors.

Conclusions:

  • Candida infections in the elderly require specialized management approaches.
  • Addressing medication-related risks is crucial for effective treatment outcomes.
  • Further research and clinical guidelines are needed for optimizing antifungal therapy in geriatric patients.